AstraZeneca, Kanas City Southern rise; Carnival, Humana fall

Monday, March 22, 2021 | The Associated Press

NEW YORK (AP) — Stocks that traded heavily or had substantial price changes Monday:

AstraZeneca Plc., up $1.99 to $51.20.

The drug developer reported encouraging results from a study of its COVID-19 vaccine.

SVB Financial Group, down $32.85 to $511.76.

The financial services company plans to publicly offer 2 million shares of stock.

Humana Inc., down $5.45 to $404.37.

The health insurer's chief financial officer, Brian Kane, is resigning in June.

Applied Materials Inc., up $4.47 to $119.33.

The chipmaking equipment maker's board of directors approved a $7.5 billion stock buyback plan.

Cubic Corp., up $5.50 to $75.20.

The electronics company received a counter offer from Singapore Technologies to rival its deal with Veritas and Evergreen Coast Capital.

Carnival Corp., down $1.48 to $27.48.

The cruise line operator said Costa Cruises in Italy will remain suspended until May 1st.

Synnex Corp., up $6.66 to $109.86.

The high-tech contractor is merging with Tech Data in a deal valued at $7.2 billion.

Kansas City Southern, up $24.93 to $249.09.

Canadian Pacific Railway is buying the railroad operator for about $25 billion in a cash and stock deal.

Companies Mentioned in This Article

CompanyMarketRank™Current PricePrice ChangeDividend YieldP/E RatioConsensus RatingConsensus Price Target
Kansas City Southern (KSU)1.9$249.09+11.1%0.87%41.17Buy$212.68
Humana (HUM)2.3$404.37-1.3%0.62%12.96Buy$462.10
SVB Financial Group (SIVB)1.5$511.76-6.0%N/A24.96Buy$423.60
SYNNEX (SNX)2.1$109.86+6.5%0.73%10.77Buy$116.63
Cubic (CUB)1.4$75.20+7.9%0.36%-578.46Hold$65.20
Carnival Co. & (CCL)1.3$27.48-5.1%N/A-2.67Hold$20.54
Compare These Stocks  Add These Stocks to My Watchlist 


Analysts Hate These 12 Stocks

When a single Wall Street analyst downgrades one of your stocks, you might think they are just having a bad day or have an incorrect investment thesis. One downgrade typically won't have a significant impact on the price of one of your stocks, but what if analysts repeatedly downgraded a company over the last 30, 60, or 90 days? You would know something is seriously wrong.

Today, we invite you to take a free exclusive look at our up-to-the-minute list of 12 "Most Downgraded" stocks. These are true strong sell stocks. Analysts are abandoning them in droves and issuing rare downgrades and sell ratings. If any of these stocks are lurking around in your portfolio, seriously consider whether or not they still belong in your portfolio. .

View the "Analysts Hate These 12 Stocks".

MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | [email protected] | (844) 978-6257
MarketBeat does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security. Learn more.

Our Accessibility Statement
Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.